Evidence map›Paper›PMID 28843644›Full record

ArticleNeuroImage2014

Corrigendum to "Systemic inflammation alters central 5-HT function as determined by pharmacological MRI" [Neuroimage 75 (2013) 177-186].

Yvonne Couch, Chris J Martin, Clare Howarth, Josie Raley, Alexandre A Khrapitchev, Michael Stratford, Trevor Sharp, Nicola R Sibson, Daniel C Anthony

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NeuroImage, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yvonne CouchDepartment of Pharmacology, University of Oxford, Mansfield Rd., Oxford OX1 3QT, UK; CR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.
Chris J MartinCR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.
Clare HowarthCR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.
Josie RaleyCR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.
Alexandre A KhrapitchevCR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.
Michael StratfordCR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.
Trevor SharpDepartment of Pharmacology, University of Oxford, Mansfield Rd., Oxford OX1 3QT, UK.
Nicola R SibsonCR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK. Electronic address: nicola.sibson@oncology.ox.ac.uk.
Daniel C AnthonyDepartment of Pharmacology, University of Oxford, Mansfield Rd., Oxford OX1 3QT, UK.
University of Oxford · GBChurchill Hospital · GBCRUK/MRC Oxford Institute for Radiation Oncology · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28843644
PMCPMC5614801
OpenAlexW2071630455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.